WARNING!
This is an older article that may not reflect Dr. Mercola’s current view on this topic. Use our search engine to find Dr. Mercola’s latest position on any health topic.
The extent to which the recession has cut into high-value research and development jobs in the pharmaceutical industry will be apparent soon as job losses in the industry climb to an additional 12,000.
GlaxoSmithKline (GSK), the British drugs group, will announce plans for further restructuring with the loss of 4,000 jobs, nearly half in the research and development departments.